Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033687 (
proteinuria
)
24,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, a novel heterozygous missense mutation c.T1421G (p. L474R) in the
PODXL
gene encoding podocalyxin was identified in an autosomal dominant focal segmental glomerulosclerosis (AD-FSGS) pedigree. However, this
PODXL
mutation appeared not to impair podocalyxin function, and it is necessary to identify new
PODXL
mutations and determine their causative role for FSGS. In the present study, we report the identification of a heterozygous nonsense
PODXL
mutation (c.C976T; p. Arg326X) in a Chinese pedigree featured by
proteinuria
and renal insufficiency with AD inheritance by whole exome sequencing (WES). Total mRNA and
PODXL protein
abundance were decreased in available peripheral blood cell samples of two affected patients undergoing hemodialysis, compared with those in healthy controls and hemodialysis controls without
PODXL
mutation. We identified another novel
PODXL
heterozygous nonsense mutation (c.C1133G; p.Ser378X) in a British-Indian pedigree of AD-FSGS by WES.
In vitro
study showed that, human embryonic kidney 293T cells transfected with the pEGFP-PODXL-Arg326X or pEGFP-PODXL-Ser378X plasmid expressed significantly lower mRNA and
PODXL protein
compared with cells transfected with the wild-type plasmid. Blocking nonsense-mediated mRNA decay (NMD) significantly restored the amount of mutant mRNA and PODXL proteins, which indicated that the pathogenic effect of
PODXL
nonsense mutations is likely due to NMD, resulting in podocalyxin deficiency. Functional consequences caused by the
PODXL
nonsense mutations were inferred by siRNA knockdown in cultured podocytes and podocalyxin down-regulation by siRNA resulted in decreased RhoA and ezrin activities, cell migration and stress fiber formation. Our results provided new data implicating heterozygous
PODXL
nonsense mutations in the development of FSGS.
...
PMID:First identification of
PODXL
nonsense mutations in autosomal dominant focal segmental glomerulosclerosis. 3073 2